keyword
https://read.qxmd.com/read/38615371/retrosigmoid-versus-middle-fossa-approach-for-hearing-and-facial-nerve-preservation-in-vestibular-schwannoma-surgery-a-systematic-review-and-comparative-meta-analysis
#21
REVIEW
Lucca B Palavani, Sávio Batista, Filipi Fim Andreão, Leonardo de Barros Oliveira, Guilherme Melo Silva, Stefan Koester, João F Barbieri, Raphael Bertani, Vinicius Trindade Gomes da Silva, Marcus Acioly, Wellingson S Paiva, Erion J De Andrade, Marcio S Rassi
BACKGROUND: Vestibular schwannomas (VS) are benign tumors arising from vestibular nerve's Schwann cells. Surgical resection via retrosigmoid (RS) or middle fossa (MF) is standard, but the optimal approach remains debated. This meta-analysis evaluated RS and MF approaches for VS management, emphasizing hearing preservation and Cranial nerve seven (CN VII) outcomes stratified by tumor size. METHODS: Systematic searches across PubMed, Cochrane, Web of Science, and Embase identified relevant studies...
April 13, 2024: Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia
https://read.qxmd.com/read/38614827/imaging-and-liquid-biopsy-for-distinguishing-true-progression-from-pseudoprogression-in-gliomas-current-advances-and-challenges
#22
REVIEW
Kaishu Li, Qihui Zhu, Junyi Yang, Yin Zheng, Siyuan Du, Meihui Song, Qian Peng, Runwei Yang, Yawei Liu, Ling Qi
RATIONALE AND OBJECTIVES: Gliomas are aggressive brain tumors with a poor prognosis. Assessing treatment response is challenging because magnetic resonance imaging (MRI) may not distinguish true progression (TP) from pseudoprogression (PsP). This review aims to discuss imaging techniques and liquid biopsies used to distinguish TP from PsP. MATERIALS AND METHODS: This review synthesizes existing literature to examine advances in imaging techniques, such as magnetic resonance diffusion imaging (MRDI), perfusion-weighted imaging (PWI) MRI, and liquid biopsies, for identifying TP or PsP through tumor markers and tissue characteristics...
April 12, 2024: Academic Radiology
https://read.qxmd.com/read/38614532/challenges-in-radiological-evaluation-of-brain-metastases-beyond-progression
#23
JOURNAL ARTICLE
A Ortiz de Mendivil, P Martín-Medina, L García-Cañamaque, B Jiménez-Munarriz, R Ciérvide, J Diamantopoulos
MRI is the cornerstone in the evaluation of brain metastases. The clinical challenges lie in discriminating metastases from mimickers such as infections or primary tumors and in evaluating the response to treatment. The latter sometimes leads to growth, which must be framed as pseudo-progression or radionecrosis, both inflammatory phenomena attributable to treatment, or be considered as recurrence. To meet these needs, imaging techniques are the subject of constant research. However, an exponential growth after radiotherapy must be interpreted with caution, even in the presence of results suspicious of tumor progression by advanced techniques, because it may be due to inflammatory changes...
2024: Radiología
https://read.qxmd.com/read/38613996/the-use-of-a-selective-nontoxic-dual-acting-peptide-for-breast-cancer-patients-with-brain-metastasis
#24
JOURNAL ARTICLE
Marco Cavaco, Clara Pérez-Peinado, Javier Valle, Ruben D M Silva, Lurdes Gano, João D G Correia, David Andreu, Miguel A R B Castanho, Vera Neves
Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by the absence of commonly targeted receptors. Unspecific chemotherapy is currently the main therapeutic option, with poor results. Another major challenge is the frequent appearance of brain metastasis (BM) associated with a significant decrease in patient overall survival. The treatment of BM is even more challenging due to the presence of the blood-brain barrier (BBB). Here, we present a dual-acting peptide (PepH3-vCPP2319) designed to tackle TNBC/BM, in which a TNBC-specific anticancer peptide (ACP) motif (vCPP2319) is joined to a BBB peptide shuttle (BBBpS) motif (PepH3)...
April 12, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38613866/phosphoproteomic-profiling-identifies-dnmt1-as-a-key-substrate-of-beta-iv-spectrin-dependent-erk-mapk-signaling-in-suppressing-angiogenesis
#25
JOURNAL ARTICLE
Paola Cruz Flores, Tasmia Ahmed, Julia Podgorski, Hannah R Ortiz, Paul R Langlais, Karthikeyan Mythreye, Nam Y Lee
βIV-spectrin is a membrane-associated cytoskeletal protein that maintains the structural stability of cell membranes and integral proteins such as ion channels and transporters. Its biological functions are best characterized in the brain and heart, although recently we discovered a fundamental new role in the vascular system. Using cellular and genetic mouse models, we reported that βIV-spectrin acts as a critical regulator of developmental and tumor-associated angiogenesis. βIV-spectrin was shown to selectively express in proliferating endothelial cells (EC) and suppress VEGF/VEGFR2 signaling by enhancing receptor internalization and degradation...
April 10, 2024: Biochemical and Biophysical Research Communications
https://read.qxmd.com/read/38613388/quantifying-the-activity-profile-of-aso-and-sirna-conjugates-in-glioblastoma-xenograft-tumors-in-vivo
#26
JOURNAL ARTICLE
Samantha L Sarli, Hassan H Fakih, Karen Kelly, Gitali Devi, Julia M Rembetsy-Brown, Holly R McEachern, Chantal M Ferguson, Dimas Echeverria, Jonathan Lee, Jacquelyn Sousa, Hanadi F Sleiman, Anastasia Khvorova, Jonathan K Watts
Glioblastoma multiforme is a universally lethal brain tumor that largely resists current surgical and drug interventions. Despite important advancements in understanding GBM biology, the invasiveness and heterogeneity of these tumors has made it challenging to develop effective therapies. Therapeutic oligonucleotides-antisense oligonucleotides and small-interfering RNAs-are chemically modified nucleic acids that can silence gene expression in the brain. However, activity of these oligonucleotides in brain tumors remains inadequately characterized...
April 13, 2024: Nucleic Acids Research
https://read.qxmd.com/read/38613219/the-application-strategy-of-liposomes-in-organ-targeting-therapy
#27
REVIEW
Zengyu Xun, Tianqi Li, Xue Xue
Liposomes-microscopic phospholipid bubbles with bilayered membrane structure-have been a focal point in drug delivery research for the past 30 years. Current liposomes possess a blend of biocompatibility, drug loading efficiency, prolonged circulation and targeted delivery. Tailored liposomes, varying in size, charge, lipid composition, and ratio, have been developed to address diseases in specific organs, thereby enhancing drug circulation, accumulation at lesion sites, intracellular delivery, and treatment efficacy for various organ-specific diseases...
2024: Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
https://read.qxmd.com/read/38611962/new-avenues-and-major-achievements-in-phytocompounds-research-for-glioblastoma-therapy
#28
REVIEW
Aleksandra Majchrzak-Celińska, Elżbieta Studzińska-Sroka
Phytocompounds have been evaluated for their anti-glioblastoma actions for decades, with promising results from preclinical studies but only limited translation into clinics. Indeed, by targeting multiple signaling pathways deregulated in cancer, they often show high efficacy in the in vitro studies, but their poor bioavailability, low tumor accumulation, and rapid clearance compromise their efficacy in vivo. Here, we present the new avenues in phytocompound research for the improvement of glioblastoma therapy, including the ways to enhance the response to temozolomide using phytochemicals, the current focus on phytocompound-based immunotherapy, or the use of phytocompounds as photosensitizers in photodynamic therapy...
April 8, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38610031/pamiparib-as-consolidation-treatment-after-concurrent-chemoradiotherapy-of-limited-stage-small-cell-lung-cancer-a-single-arm-open-label-phase-2-trial
#29
JOURNAL ARTICLE
Jiuang Mao, Jianjiao Ni, Li Chu, Xiao Chu, Dayu Xu, Xi Yang, Zhengfei Zhu
BACKGROUND: Small cell lung cancer (SCLC) is highly invasive with poor prognosis, and its treatment has historically been hindered due to the absence of targetable driver genomic alterations. However, the high genomic instability and replication stress in SCLC have made poly(ADP-ribose) polymerases (PARPs) inhibitors a focus of research. Pamiparib is an orally available PARP1/2 inhibitor with high selectivity, strong PARP trapping activity, and excellent brain penetration. Utilizing pamiparib as consolidation maintenance therapy in limited-stage SCLC holds promise for improving survival outcomes and offering a viable therapeutic approach...
April 12, 2024: Radiation Oncology
https://read.qxmd.com/read/38608296/ventricular-catheter-tissue-obstruction-and-shunt-malfunction-in-9-hydrocephalus-etiologies
#30
JOURNAL ARTICLE
Maria Garcia-Bonilla, Prashant Hariharan, Jacob Gluski, Miguel A Ruiz-Cardozo, Ayodamola Otun, Diego M Morales, Neena I Marupudi, William E Whitehead, Andrew Jea, Brandon G Rocque, James P McAllister, David D Limbrick, Carolyn A Harris
OBJECTIVE: Hydrocephalus is a neurological disorder with an incidence of 80-125 per 100,000 births in the United States. The most common treatment, ventricular shunting, has a failure rate of up to 85% within 10 years of placement. The authors aimed to analyze the association between ventricular catheter (VC) tissue obstructions and shunt malfunction for each hydrocephalus etiology. METHODS: Patient information was collected from 5 hospitals and entered into a REDCap (Research Electronic Data Capture) database by hydrocephalus etiology...
April 12, 2024: Journal of Neurosurgery. Pediatrics
https://read.qxmd.com/read/38607297/roles-and-interactions-of-tumor-microenvironment-components-in-medulloblastoma-with-implications-for-novel-therapeutics
#31
REVIEW
Hanjie Yang, Min Li, Yuhao Deng, Huantao Wen, Minjie Luo, Wangming Zhang
Medulloblastomas, the most common malignant pediatric brain tumors, can be classified into the wingless, sonic hedgehog (SHH), group 3, and group 4 subgroups. Among them, the SHH subgroup with the TP53 mutation and group 3 generally present with the worst patient outcomes due to their high rates of recurrence and metastasis. A novel and effective treatment for refractory medulloblastomas is urgently needed. To date, the tumor microenvironment (TME) has been shown to influence tumor growth, recurrence, and metastasis through immunosuppression, angiogenesis, and chronic inflammation...
April 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38606460/recent-advances-in-targeted-drug-delivery-for-the-treatment-of-glioblastoma
#32
REVIEW
Meng Mao, Yingjie Wu, Qiang He
Glioblastoma multiforme (GBM) is one of the highly malignant brain tumors characterized by significant morbidity and mortality. Despite the recent advancements in the treatment of GBM, major challenges persist in achieving controlled drug delivery to tumors. The management of GBM poses considerable difficulties primarily due to unresolved issues in the blood-brain barrier (BBB)/blood-brain tumor barrier (BBTB) and GBM microenvironment. These factors limit the uptake of anti-cancer drugs by the tumor, thus limiting the therapeutic options...
April 12, 2024: Nanoscale
https://read.qxmd.com/read/38606262/self-shielding-gyroscopic-radiosurgery-a-prospective-experience-and-analysis-of-the-first-100-patients
#33
JOURNAL ARTICLE
Felix Ehret, Nadja Kohlhase, Dochka Eftimova, Theresa Hofmann, Christoph Fürweger, Alfred Haidenberger, Markus Kufeld, Alexander Muacevic, Antonio Santacroce
Background Stereotactic radiosurgery is a well-established treatment option for the management of various benign and malignant brain tumors. It can be delivered with several treatment platforms, usually requiring shielded radiation vaults to meet regulatory safety requirements. Recent technical advances have led to the first self-shielding platform enabling the delivery of gyroscopic radiosurgery (GRS). Given the limited number of GRS treatment platforms, the novelty of its characteristics, and the lack of available data, we report our prospective experience with the first 100 patients treated with GRS...
March 2024: Curēus
https://read.qxmd.com/read/38605423/herc5-downregulation-in-non-small-cell-lung-cancer-is-associated-with-altered-energy-metabolism-and-metastasis
#34
JOURNAL ARTICLE
Svenja Schneegans, Jana Löptien, Angelika Mojzisch, Desirée Loreth, Oliver Kretz, Christoph Raschdorf, Annkathrin Hanssen, Antonia Gocke, Bente Siebels, Karthikeyan Gunasekaran, Yi Ding, Leticia Oliveira-Ferrer, Laura Brylka, Thorsten Schinke, Hartmut Schlüter, Ilkka Paatero, Hannah Voß, Stefan Werner, Klaus Pantel, Harriet Wikman
BACKGROUND: Metastasis is the leading cause of cancer-related death in non-small cell lung cancer (NSCLC) patients. We previously showed that low HERC5 expression predicts early tumor dissemination and a dismal prognosis in NSCLC patients. Here, we performed functional studies to unravel the mechanism underlying the "metastasis-suppressor" effect of HERC5, with a focus on mitochondrial metabolism pathways. METHODS: We assessed cell proliferation, colony formation potential, anchorage-independent growth, migration, and wound healing in NSCLC cell line models with HERC5 overexpression (OE) or knockout (KO)...
April 11, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38605349/esco2-s-oncogenic-role-in-human-tumors-a-pan-cancer-analysis-and-experimental-validation
#35
JOURNAL ARTICLE
Yue Huang, Dapeng Chen, Yi Bai, Yamin Zhang, Zhiwen Zheng, Qingfeng Fu, Bocun Yi, Yuchen Jiang, Zhihong Zhang, Jianqiang Zhu
PURPOSE: Establishment of sister chromatid cohesion N-acetyltransferase 2 (ESCO2) is involved in the mitotic S-phase adhesins acetylation and is responsible for bridging two sister chromatids. However, present ESCO2 cancer research is limited to a few cancers. No systematic pan-cancer analysis has been conducted to investigate its role in diagnosis, prognosis, and effector function. METHODS: We thoroughly examined the ESCO2 carcinogenesis in pan-cancer by combining public databases such as The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression Project (GTEx), UALCAN and Tumor Immune Single-cell Hub (TISCH)...
April 11, 2024: BMC Cancer
https://read.qxmd.com/read/38604968/-effects-and-mechanisms-of-negative-air-ions-on-blood-pressure-oxidative-stress-and-inflammation-levels-in-shr-rats
#36
JOURNAL ARTICLE
Na Li, Tianjing Wei, Mingyang Xiao, Wenfang Long, Jing Zhang, Jing Zhou, Lianhua Liu, Qiongjun Xu, Xiaobo Lu, Sha Xiao
OBJECTIVE: To investigate the effects and possible mechanisms of negative air ions(NAIs) on blood pressure, oxidative stress, and inflammatory status in spontaneous hypertension rats(SHR). METHODS: A total of 60 SHR(half male and half female) were randomly divided into one-month and three-month groups, 30 rats per groups, based on the duration of the intervention. Each group was further randomized into three groups based on the daily intervention time: SHR control group, 2 h NAIs-SHR group, and 6 h NAIs-SHR group, 10 rats per groups...
March 2024: Wei Sheng Yan Jiu, Journal of Hygiene Research
https://read.qxmd.com/read/38601620/brain-tumor-recognition-by-an-optimized-deep-network-utilizing-ammended-grasshopper-optimization
#37
JOURNAL ARTICLE
Jing Zhu, Chuang Gu, Li Wei, Hanjuan Li, Rui Jiang, Fatima Rashid Sheykhahmad
Brain tumors are abnormal cell masses that can get originated in the brain spread from other organs. They can be categorized as either malignant (cancerous) or benign (noncancerous), and their growth rates and locations can impact the functioning of the nerve system. The timely detection of brain tumors is crucial for effective treatment and prognosis. In this study, a new approach has been proposed for diagnosing brain tumors using deep learning and a meta-heuristic algorithm. The method involves three main steps: (1) extracting features from brain MRI images using AlexNet, (2) reducing the complexity of AlexNet by employing an Extreme Learning Machine (ELM) network as a classification layer, and (3) fine-tuning the parameters of the ELM network using an Amended Grasshopper Optimization Algorithm (AGOA)...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38600340/eclim-sehop-how-to-develop-a-platform-to-conduct-academic-trials-for-childhood-cancer
#38
JOURNAL ARTICLE
Antonio Juan-Ribelles, Francisco Bautista, Adela Cañete, Alba Rubio-San-Simón, Anna Alonso-Saladrigues, Raquel Hladun, Susana Rives, Jose Luís Dapena, Jose María Fernández, Álvaro Lassaletta, Ofelia Cruz, Gemma Ramírez-Villar, Jose Luís Fuster, Cristina Diaz de Heredia, Miguel García-Ariza, Eduardo Quiroga, María Del Mar Andrés, Jaime Verdú-Amorós, Antonio Molinés, Blanca Herrero, Mónica López, Catalina Márquez, María Toboso, Frencisco Lendínez, Jose Gómez Sirvent, María Tallón, Guiomar Rodríguez, Tomás Acha, Lucas Moreno, Ana Fernández-Teijeiro
INTRODUCTION: ECLIM-SEHOP platform was created in 2017. Its main objective is to establish the infrastructure to allow Spanish participation into international academic collaborative clinical trials, observational studies, and registries in pediatric oncology. The aim of this manuscript is to describe the activity conducted by ECLIM-SEHOP since its creation. METHODS: The platform's database was queried to provide an overview of the studies integrally and partially supported by the organization...
April 10, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/38600050/a-rare-presentation-of-primary-cardiac-myxofibrosarcoma-case-report-and-literature-review
#39
Sepideh Soltani, Maryam Garousi, Elahe Mirzaee, Sogol Koolaji, Hengameh Nazari, Sepideh Emami, Ali Zare Mehrjardi, Amir Mohammad Arefpour
BACKGROUND: Primary cardiac myxofibrosarcoma is a rare and aggressive malignancy, with the majority of approaching strategies relying on case reports. This article provides insights into its diagnosis and treatment. CASE PRESENTATION: This paper presents the case of a 40-year-old man with sudden onset hemoptysis, leading to the diagnosis of primary cardiac myxofibrosarcoma. Treatment involved open-heart surgery to excise the left atrium tumor, followed by 6 cycles of adjuvant chemotherapy...
April 2024: Cancer reports
https://read.qxmd.com/read/38596032/adcy4-promotes-brain-metastasis-in-small-cell-lung-cancer-and-is-associated-with-energy-metabolism
#40
JOURNAL ARTICLE
Yidan Sun, Yixun Chen, Xin Zhang, Dan Yi, Fanming Kong, Linlin Zhao, Dongying Liao, Lei Chen, Qianqian Ma, Ziheng Wang
Brain metastasis (BMs) in small cell lung cancer (SCLC) has a very poor prognosis. This study combined WGCNA with the mfuzz algorithm to identify potential biomarkers in the peripheral blood of patients with BMs. By comparing the significantly differentially expressed genes present in BMs samples, we identified ADCY4 as a target for further study. Expression of ADCY4 was used to cluster mfuzz expression pattern, and 28 hub genes for functional enrichment. PPI network analysis were obtained by comparing with differentially expressed genes in BMs...
April 15, 2024: Heliyon
keyword
keyword
42941
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.